ASX - By Stock
|
IXC |
Re:
Ann: Invex Granted Key European Patent for Exenatide
|
|
ejjwj
|
104 |
16K |
4 |
18/08/21 |
18/08/21 |
ASX - By Stock
|
104
|
16K
|
4
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Invex Granted Key European Patent for Exenatide
|
|
ejjwj
|
104 |
16K |
8 |
16/08/21 |
16/08/21 |
ASX - By Stock
|
104
|
16K
|
8
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Investor Presentation
|
|
ejjwj
|
146 |
28K |
0 |
12/08/21 |
12/08/21 |
ASX - By Stock
|
146
|
28K
|
0
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Investor Presentation
|
|
ejjwj
|
146 |
28K |
2 |
16/07/21 |
16/07/21 |
ASX - By Stock
|
146
|
28K
|
2
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Investor Presentation
|
|
ejjwj
|
146 |
28K |
1 |
16/07/21 |
16/07/21 |
ASX - By Stock
|
146
|
28K
|
1
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Investor Presentation
|
|
ejjwj
|
146 |
28K |
3 |
16/07/21 |
16/07/21 |
ASX - By Stock
|
146
|
28K
|
3
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Investor Presentation
|
|
ejjwj
|
146 |
28K |
1 |
14/07/21 |
14/07/21 |
ASX - By Stock
|
146
|
28K
|
1
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Investor Presentation
|
|
ejjwj
|
146 |
28K |
1 |
12/07/21 |
12/07/21 |
ASX - By Stock
|
146
|
28K
|
1
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Investor Presentation
|
|
ejjwj
|
146 |
28K |
1 |
11/07/21 |
11/07/21 |
ASX - By Stock
|
146
|
28K
|
1
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Investor Presentation
|
|
ejjwj
|
146 |
28K |
1 |
10/07/21 |
10/07/21 |
ASX - By Stock
|
146
|
28K
|
1
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Investor Presentation
|
|
ejjwj
|
146 |
28K |
0 |
10/07/21 |
10/07/21 |
ASX - By Stock
|
146
|
28K
|
0
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Investor Presentation
|
|
ejjwj
|
146 |
28K |
0 |
10/07/21 |
10/07/21 |
ASX - By Stock
|
146
|
28K
|
0
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Investor Presentation
|
|
ejjwj
|
146 |
28K |
1 |
09/07/21 |
09/07/21 |
ASX - By Stock
|
146
|
28K
|
1
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Investor Presentation
|
|
ejjwj
|
146 |
28K |
1 |
09/07/21 |
09/07/21 |
ASX - By Stock
|
146
|
28K
|
1
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Investor Presentation
|
|
ejjwj
|
146 |
28K |
2 |
09/07/21 |
09/07/21 |
ASX - By Stock
|
146
|
28K
|
2
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Investor Presentation
|
|
ejjwj
|
146 |
28K |
1 |
09/07/21 |
09/07/21 |
ASX - By Stock
|
146
|
28K
|
1
|
|
ASX - By Stock
|
IXC |
Re:
University of Birmingham Lawsuit
|
|
ejjwj
|
53 |
14K |
1 |
04/07/21 |
04/07/21 |
ASX - By Stock
|
53
|
14K
|
1
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Investor Presentation
|
|
ejjwj
|
146 |
28K |
3 |
01/07/21 |
01/07/21 |
ASX - By Stock
|
146
|
28K
|
3
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Investor Presentation
|
|
ejjwj
|
146 |
28K |
1 |
30/06/21 |
30/06/21 |
ASX - By Stock
|
146
|
28K
|
1
|
|
ASX - By Stock
|
TLX |
Re:
Ann: TLX101 for Glioblastoma Therapy - Clinical Trial Update
|
|
ejjwj
|
30 |
13K |
1 |
25/06/21 |
25/06/21 |
ASX - By Stock
|
30
|
13K
|
1
|
|
ASX - By Stock
|
TLX |
Re:
Ann: TLX101 for Glioblastoma Therapy - Clinical Trial Update
|
|
ejjwj
|
30 |
13K |
2 |
21/06/21 |
21/06/21 |
ASX - By Stock
|
30
|
13K
|
2
|
|
ASX - By Stock
|
TLX |
Re:
Ann: TLX101 for Glioblastoma Therapy - Clinical Trial Update
|
|
ejjwj
|
30 |
13K |
3 |
21/06/21 |
21/06/21 |
ASX - By Stock
|
30
|
13K
|
3
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Investor Presentation
|
|
ejjwj
|
146 |
28K |
1 |
21/06/21 |
21/06/21 |
ASX - By Stock
|
146
|
28K
|
1
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Investor Presentation
|
|
ejjwj
|
146 |
28K |
1 |
21/06/21 |
21/06/21 |
ASX - By Stock
|
146
|
28K
|
1
|
|
ASX - By Stock
|
TLX |
Re:
Ideal time to do a capital raising
|
|
ejjwj
|
15 |
7.2K |
0 |
19/06/21 |
19/06/21 |
ASX - By Stock
|
15
|
7.2K
|
0
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Invex Receives Written Response from FDA on Type C Meeting
|
|
ejjwj
|
66 |
16K |
2 |
18/06/21 |
18/06/21 |
ASX - By Stock
|
66
|
16K
|
2
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Invex Receives Written Response from FDA on Type C Meeting
|
|
ejjwj
|
66 |
16K |
0 |
15/06/21 |
15/06/21 |
ASX - By Stock
|
66
|
16K
|
0
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Invex Receives Written Response from FDA on Type C Meeting
|
|
ejjwj
|
66 |
16K |
0 |
15/06/21 |
15/06/21 |
ASX - By Stock
|
66
|
16K
|
0
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Invex Receives Written Response from FDA on Type C Meeting
|
|
ejjwj
|
66 |
16K |
2 |
15/06/21 |
15/06/21 |
ASX - By Stock
|
66
|
16K
|
2
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Invex Receives Written Response from FDA on Type C Meeting
|
|
ejjwj
|
66 |
16K |
2 |
15/06/21 |
15/06/21 |
ASX - By Stock
|
66
|
16K
|
2
|
|
ASX - By Stock
|
IXC |
Re:
University of Birmingham Lawsuit
|
|
ejjwj
|
53 |
14K |
0 |
12/06/21 |
12/06/21 |
ASX - By Stock
|
53
|
14K
|
0
|
|
ASX - By Stock
|
IXC |
Re:
University of Birmingham Lawsuit
|
|
ejjwj
|
53 |
14K |
0 |
12/06/21 |
12/06/21 |
ASX - By Stock
|
53
|
14K
|
0
|
|
ASX - By Stock
|
IXC |
Re:
University of Birmingham Lawsuit
|
|
ejjwj
|
53 |
14K |
1 |
12/06/21 |
12/06/21 |
ASX - By Stock
|
53
|
14K
|
1
|
|
ASX - By Stock
|
IXC |
Re:
University of Birmingham Lawsuit
|
|
ejjwj
|
53 |
14K |
6 |
12/06/21 |
12/06/21 |
ASX - By Stock
|
53
|
14K
|
6
|
|
ASX - By Stock
|
IXC |
Re:
University of Birmingham Lawsuit
|
|
ejjwj
|
53 |
14K |
0 |
11/06/21 |
11/06/21 |
ASX - By Stock
|
53
|
14K
|
0
|
|
ASX - By Stock
|
IXC |
Re:
University of Birmingham Lawsuit
|
|
ejjwj
|
53 |
14K |
1 |
11/06/21 |
11/06/21 |
ASX - By Stock
|
53
|
14K
|
1
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Invex Granted Type C Meeting with FDA
|
|
ejjwj
|
133 |
31K |
1 |
10/06/21 |
10/06/21 |
ASX - By Stock
|
133
|
31K
|
1
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Invex Granted Type C Meeting with FDA
|
|
ejjwj
|
133 |
31K |
0 |
09/06/21 |
09/06/21 |
ASX - By Stock
|
133
|
31K
|
0
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Invex Granted Type C Meeting with FDA
|
|
ejjwj
|
133 |
31K |
2 |
08/06/21 |
08/06/21 |
ASX - By Stock
|
133
|
31K
|
2
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Invex Granted Type C Meeting with FDA
|
|
ejjwj
|
133 |
31K |
1 |
08/06/21 |
08/06/21 |
ASX - By Stock
|
133
|
31K
|
1
|
|
ASX - By Stock
|
TLX |
Re:
Shorters discover Telix
|
|
ejjwj
|
234 |
85K |
5 |
03/06/21 |
03/06/21 |
ASX - By Stock
|
234
|
85K
|
5
|
|
ASX - By Stock
|
TLX |
Re:
Shorters discover Telix
|
|
ejjwj
|
234 |
85K |
2 |
02/06/21 |
02/06/21 |
ASX - By Stock
|
234
|
85K
|
2
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Invex Granted Type C Meeting with FDA
|
|
ejjwj
|
133 |
31K |
4 |
02/06/21 |
02/06/21 |
ASX - By Stock
|
133
|
31K
|
4
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Invex Granted Type C Meeting with FDA
|
|
ejjwj
|
133 |
31K |
5 |
30/05/21 |
30/05/21 |
ASX - By Stock
|
133
|
31K
|
5
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Invex Files Pre-IND/Type B Meeting Request with US FDA
|
|
ejjwj
|
61 |
16K |
3 |
19/05/21 |
19/05/21 |
ASX - By Stock
|
61
|
16K
|
3
|
|
ASX - By Stock
|
TLX |
Re:
Shorters discover Telix
|
|
ejjwj
|
234 |
85K |
7 |
13/05/21 |
13/05/21 |
ASX - By Stock
|
234
|
85K
|
7
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Invex Granted Type C Meeting with FDA
|
|
ejjwj
|
133 |
31K |
5 |
02/05/21 |
02/05/21 |
ASX - By Stock
|
133
|
31K
|
5
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Invex Granted Type C Meeting with FDA
|
|
ejjwj
|
133 |
31K |
4 |
25/04/21 |
25/04/21 |
ASX - By Stock
|
133
|
31K
|
4
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Invex Files Pre-IND/Type B Meeting Request with US FDA
|
|
ejjwj
|
61 |
16K |
8 |
08/04/21 |
08/04/21 |
ASX - By Stock
|
61
|
16K
|
8
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Invex Files Pre-IND/Type B Meeting Request with US FDA
|
|
ejjwj
|
61 |
16K |
1 |
06/04/21 |
06/04/21 |
ASX - By Stock
|
61
|
16K
|
1
|
|